08/27/2024 5:46 PM | TScan Therapeutics (Issuer) ZDRAVESKI ZORAN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/27/2024 5:57 PM | Klencke Barbara (Reporting) TScan Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/23/2024 4:50 PM | TScan Therapeutics (Subject) ZDRAVESKI ZORAN (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/12/2024 6:30 AM | TScan Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/12/2024 6:15 AM | TScan Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/14/2024 3:20 PM | Nicholson Garry A (Reporting) TScan Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2024 3:20 PM | Gruia Gabriela (Reporting) TScan Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
06/14/2024 3:20 PM | Klencke Barbara (Reporting) TScan Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2024 3:20 PM | Dorton Katina (Reporting) TScan Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2024 3:20 PM | TScan Therapeutics (Issuer) Woods Keith (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2024 6:15 AM | TScan Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/13/2024 6:15 AM | TScan Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/13/2024 6:30 AM | TScan Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/03/2024 3:05 PM | Louis Chrystal (Reporting) TScan Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/23/2024 3:17 PM | 667, L.P. (Reporting) Baker Bros. Advisors LLC (0001580575) (Reporting) BAKER BROS. ADVISORS LP (Reporting) Baker Brothers Life Sciences LP (Reporting) BAKER FELIX (Reporting) BAKER JULIAN (Reporting) TScan Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/23/2024 3:25 PM | BAKER BROS. ADVISORS LP (Filed by) TScan Therapeutics (Subject)
| Form SC 13D/A | |
04/23/2024 3:15 PM | Lynx1 Capital Management LP (Reporting) Nichols Weston (Reporting) TScan Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/17/2024 8:58 PM | TScan Therapeutics (Filer)
| Form 424B5 | |
04/17/2024 5:25 AM | TScan Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/17/2024 5:20 AM | TScan Therapeutics (Subject)
| Form FWP | |
04/16/2024 4:21 PM | TScan Therapeutics (Filer)
| Form 424B5 | |
04/16/2024 3:16 PM | TScan Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/14/2024 11:15 PM | TScan Therapeutics (Filer)
| Form EFFECT | |
04/10/2024 6:30 AM | TScan Therapeutics (Filer)
| Form 10-K/A | |
04/08/2024 7:17 AM | TScan Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/06/2024 6:30 AM | TScan Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/06/2024 6:15 AM | TScan Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2024 3:45 PM | K2 HealthVentures Equity Trust LLC (Filed by) TScan Therapeutics (Subject)
| Form SC 13G/A | |
02/08/2024 5:02 AM | Pitango HealthTech Fund I, L.P. (Filed by) TScan Therapeutics (Subject)
| Form SC 13G/A | |
02/07/2024 6:45 AM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by) TScan Therapeutics (Subject)
| Form SC 13G/A | |
02/02/2024 3:21 PM | Amello Jason (Reporting) TScan Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/29/2024 6:15 AM | TScan Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/21/2023 4:00 PM | BARBERICH TIMOTHY J (Reporting) TScan Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/18/2023 5:01 PM | Klencke Barbara (Reporting) TScan Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/11/2023 7:00 AM | TScan Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/08/2023 7:15 AM | TScan Therapeutics (Issuer) TScan Therapeutics (Issuer) Woods Keith (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
12/08/2023 7:20 AM | TScan Therapeutics (Issuer) TScan Therapeutics (Issuer) Woods Keith (Reporting) Woods Keith (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/07/2023 6:15 AM | TScan Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/09/2023 6:15 AM | TScan Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/09/2023 6:30 AM | TScan Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |